Tsubakimoto Chain entered into a basic agreement with Magnes AG for comprehensive collaboration. The companies aim to develop the Human Assist Business in Japan, including AI-equipped smart shoes designed to improve freezing of gait in people with Parkinson's disease.
Tsubakimoto Chain entered into a basic agreement with Magnes AG for comprehensive collaboration to promote business development in the medical and nursing-care fields. Going forward, the companies will work with medical institutions in Japan to develop products and services based on the needs of patients and frontline personnel, with the aim of supporting the independence of people with walking difficulties and improving their quality of life.
The new Human Assist Business will develop robotics-based medical bed transport assistance systems and powered exoskeletons, as well as devices aimed at improving freezing of gait in people with Parkinson's disease.
Magnes AG is a Switzerland-based medical technology company that developed the AI-equipped NUSHU™ smart shoes. It has obtained European MDR certification and is listed with the U.S. FDA, with the aim of improving mobility and quality of life in the field of neurological rehabilitation.
The project is part of Tsubakimoto Chain's efforts to address social issues under its Long-Term Vision 2030, with the aim of accelerating the practical application of the products and services in Japan.